Highly Cited: Several DZNE Scientists Among the World’s Most Influential Researchers
Researchers whose studies are frequently cited in scientific journals are considered influential, as being…
PROSA
General
Changes in speech and language patterns in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are well known but vary significantly by underlying disease and…
back to overview
GENERATION HD2
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals With…
Chan Zuckerberg Initiative funds project by Dr. Sabine Krabbe.
Bonn/Germany, November 10, 2023. Neurodegenerative diseases like Alzheimer’s and Parkinson’s can be associated to depression and…
Gaining Knowledge in Virtual Spaces
Through a project funded with three million euros by the Ministry of Culture and Science of North-Rhine Westphalia (NRW), scientists in Bonn and Dortmund aim…
Our strategic partners
Contact
technologietransfer@dzne.de
Industry Cooperations
The fight against neurodegenerative diseases cannot be achieved without strong partners. Teaming up with…
European Research Council awards “Starting Grant” to Dr. Dragomir Milovanovic.
Berlin/Germany, November 6, 2023. Dr. Dragomir Milovanovic, a neuroscientist at DZNE’s Berlin site, has been awarded an…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
